Longevity Health Holdings Inc.
XAGEOTCHealthcare● Active
$0.31
$-0.03(-8.76%)
Market Cap$443463
P/E Ratio—
52W High$8.27
52W Low$0.23
Longevity Health Holdings Inc. (XAGE) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · XAGE · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.91M | $0.05M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.82M | $0.01M | $0.12M | $0.24M | $0.00M |
| Gross Profit | $1.09M | $0.04M | ($0.12M) | ($0.24M) | $0.00M |
| Gross Margin %(computed) | 57.23% | 87.37% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.79M | $1.05M | $2.50M | $2.20M | $0.98M |
| G&A Expenses | $5.91M | $3.72M | $0.00M | $3.22M | $0.86M |
| Total Operating Expenses | $8.20M | $5.04M | $5.09M | $5.27M | $1.94M |
| Operating Income | ($7.11M) | ($5.00M) | ($5.22M) | ($5.51M) | ($0.47M) |
| Operating Margin %(computed) | -371.58% | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $2.25M | $0.01M |
| Interest Expense | $0.02M | $0.05M | $0.89M | $3.75M | $2.50M |
| Income Before Tax | ($6.87M) | ($10.75M) | ($16.21M) | ($9.05M) | ($0.33M) |
| Income Tax Expense | $0.04M | ($0.10M) | $0.00M | $0.00M | $0.00M |
| Net Income | ($6.91M) | ($10.37M) | ($15.45M) | ($9.05M) | ($6.48M) |
| Net Margin %(computed) | -361.00% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.01 | $-0.50 | $-0.74 | $-0.50 | $-0.01 |
| Wtd Avg Shares | 1.72M | 20.91M | 20.77M | 19.77M | 19.77M |
| EBITDA | ($6.64M) | ($10.50M) | ($15.19M) | ($5.06M) | ($0.09M) |
| EBITDA Margin %(computed) | -346.91% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Longevity Health Holdings Inc. data
About Longevity Health Holdings Inc. (XAGE) Income Statement
Longevity Health Holdings Inc. (XAGE) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, XAGE reported revenue of $0.00B, gross profit of $0.00B (gross margin 57.23%), and net income of ($0.01B) — a net profit margin of -361.00%.
Frequently asked questions
XAGE · 4 questionsLongevity Health Holdings Inc. (XAGE) reported revenue of $0.00B for 2025, up 3701.4% year-over-year.
XAGE revenueXAGE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09